Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07829029 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ancillary Nocturnal Urinary Symptoms Analyses for TRIUMPH

Name: Ancillary Nocturnal Urinary Symptoms Analyses for TRIUMPH — clinical trial record (NCT07829029)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorUniversity of California, San Francisco

Started2022-10-04

View on ClinicalTrials.gov ↗

University of California, San Francisco

637 trials monitored

See 53 trials at risk

The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed tocompare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonistbladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other aging-related functional outcomes in ambulatory older women with urgency-predominant urinaryincontinence and either normal or mildly impaired cognitive function at baseline.

Trial Details

NCT Number	NCT07829029
Lead Sponsor	University of California, San Francisco Collaborators: National Institute on Aging (NIA)
Conditions	Nocturia
Enrollment	270 participants
Start Date	2022-10-04
Primary Completion	2027-05-02 (estimated)
Study Completion	2027-05-02 (estimated)
Updated on ClinicalTrials.gov	2026-09-22